insulin icodec/semaglutide Media Centre Weekly Icodec versus Daily Glargine
Description
0$ Down, 0% Interest
This trend is further corroborated by another study, which, using claims data, observed a notable increase in the first-line use of GLP-1RAs from 6% to 18% from January 2022 to May 2023
PMID 26310692
Nearly half of Gen Z and Gen X consumers said they would restart if insurance covered the cost
